The Centers for Medicare & Medicaid Services (CMS) has awarded the Part D Qualified Independent Contractor (QIC) contract to C2C Innovative Solutions, Inc. (C2C).
Starting Feb. 1, 2021, C2C will be responsible for conducting reconsiderations of adverse Part D coverage determinations and redeterminations, adverse redeterminations related to an at-risk determination under a drug management program (DMP). For more information, check out this CMS memorandum.
Please note, MAXIMUS will continue to serve as the Part C QIC.
